PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2036297-1	1991	Chemotaxis of human neutrophils in response to a gradient of the chemotactic peptide, fmet-leu-phe (FMLP), was measured by the under-agarose technique.	Sepharose	133-140	formyl peptide receptor 1	Homo sapiens	86-98	
2036297-1	1991	Chemotaxis of human neutrophils in response to a gradient of the chemotactic peptide, fmet-leu-phe (FMLP), was measured by the under-agarose technique.	Sepharose	133-140	formyl peptide receptor 1	Homo sapiens	100-104	
2868456-1	1986	Using the under-agarose chemotaxis assay, addition of compounds known to inhibit chemotaxis of leukocytes toward N-f-Met-Leu-Phe (FMLP) was made to the first well in a line of three wells, leukocytes to the middle well, and a slight excess of FMLP to the third well.	Sepharose	16-23	formyl peptide receptor 1	Homo sapiens	130-134	
2830314-5	1988	In contrast, rH TNF-alpha reduced or abolished neutrophil locomotion under agarose in response to a gradient of FMLP.	Sepharose	75-82	formyl peptide receptor 1	Homo sapiens	112-116	
3446289-2	1987	When diclofenac sodium, was incorporated into the agarose gel at various concentrations below 100 micrograms/ml, it inhibited, in a dose-dependent fashion, spontaneous PMN migration and the directional migrations induced by both C5a-activated serum and peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP).	Sepharose	50-57	formyl peptide receptor 1	Homo sapiens	302-306	
10352300-3	1999	Neutrophil migration in response to fMLP was assessed using an agarose overlay method with slides precoated with fibronectin (Fn) +/- beta-glucan.	Sepharose	63-70	formyl peptide receptor 1	Homo sapiens	36-40	
4078307-8	1985	A more direct demonstration of chemotaxis was achieved by the second assay in which an agarose slab containing FMLP was incorporated into a gel, and the paths of nearby neutrophils were filmed.	Sepharose	87-94	formyl peptide receptor 1	Homo sapiens	111-115	
6756410-2	1982	To gain insight into the mechanism of these effects, we measured the oriented PMN migration under agarose induced, in the presence and absence of PBZ, by FMLP, zymosan-activated serum and Klebsiella pneumoniae culture supernatant.	Sepharose	98-105	formyl peptide receptor 1	Homo sapiens	154-158	
27655676-4	2016	Using an under agarose chemotaxis assay, we observed that the bacterial fMLP-induced neutrophil chemotaxis signal overrode interleukin 8 (IL-8)- and leukotriene B4 (LTB4)-induced chemotaxis signals.	Sepharose	15-22	formyl peptide receptor 1	Homo sapiens	72-76	
27144520-6	2016	The under agarose migration assay demonstrated that LPS stimulation promoted migration to the ligand of FPR1, N-Formyl-Met-Leu-Phe (fMLP) but that CORM-2 treatment inhibited this promotion.	Sepharose	10-17	formyl peptide receptor 1	Homo sapiens	104-108	
17675514-2	2007	Recombinant histidine-tagged FPR (rHis-FPR) was purified in lysophosphatidyl glycerol (LPG) by Ni(2+)-NTA agarose chromatography to >95% purity with high yield.	Sepharose	106-113	formyl peptide receptor 1	Homo sapiens	29-32	
2997330-4	1985	The chemotactic tripeptide FMLP was incorporated into 1% agarose containing 0.1% bovine serum albumin (BSA) to give a concentration range of 10(-8) M to 10(-6) M FMLP.	Sepharose	57-64	formyl peptide receptor 1	Homo sapiens	27-31	
2016539-6	1991	Substrate-affinity chromatography with phe-Sepharose or FMLP-Sepharose provided partial purification of enzyme activity among Mr 65,000 to 70,000 FMLP- or phe-binding proteins.	Sepharose	61-70	formyl peptide receptor 1	Homo sapiens	146-150	
2016539-6	1991	Substrate-affinity chromatography with phe-Sepharose or FMLP-Sepharose provided partial purification of enzyme activity among Mr 65,000 to 70,000 FMLP- or phe-binding proteins.	Sepharose	43-52	formyl peptide receptor 1	Homo sapiens	146-150	
2016539-6	1991	Substrate-affinity chromatography with phe-Sepharose or FMLP-Sepharose provided partial purification of enzyme activity among Mr 65,000 to 70,000 FMLP- or phe-binding proteins.	Sepharose	61-70	formyl peptide receptor 1	Homo sapiens	56-60	
1732379-11	1992	The observed ability of dapsone to inhibit neutrophil chemotaxis under agarose to FMLP and interleukin-8 may also be explained by interference with integrin-mediated adherence required for motility in this assay system.	Sepharose	71-78	formyl peptide receptor 1	Homo sapiens	82-86